Imperial Valley News Center
Deputy Secretary Sullivan's Meeting With Turkish Deputy Foreign Minister Sedat Önal
- Details
- Written by State Department
Washington, DC - Today, Deputy Secretary of State John J. Sullivan met with Turkish Deputy Foreign Minister H.E. Ambassador Sedat Önal.
FDA alerts healthcare providers, women about risks associated with improper use of rupture of membranes tests
- Details
- Written by Stephanie Caccomo
Washington, DC - The U.S. Food and Drug Administration today alerted women and their doctors about serious adverse events related to the improper use of tests intended as an aid in detecting if a pregnant woman’s water has broken (also known as a rupture of the membranes containing amniotic fluid). A rupture of the membranes (ROM) can pose immediate and severe risks to the patient and developing fetus without proper patient management and timely intervention.
NAVCENT Sailors Participate in Prototype Wear Test
- Details
- Written by Kevin J. Steinberg
Manama, Bahrain - Five Sailors assigned to Commander, U.S. Naval Forces Central Command (NAVCENT), volunteered to participate in a uniform wear test for a two-piece flame resistant organizational clothing variant since May 23.
Funkins Extra Spacious, Washable Insulated Neoprene Lunch Bags
- Details
- Written by Leah J. Cybulski
Imperial, California - Moms know the struggle of smelly lunch boxes that fail halfway through the new school year and are impossible to clean or store enough food. Named Lunch Bag of the Year in 2017 by Super-healthy Kids, Funkins Lunch Bags are a lunch time game-changer!
CDFA working with DWR on emerging groundwater recharge strategy
- Details
- Written by IVN
Sacramento, California - Later this month the California Department of Water Resources (DWR) is hosting a public workshop on Flood-MAR, an emerging water management strategy that could improve water-resources sustainability throughout the state.
FDA approves treatment for two rare types of non-Hodgkin lymphoma
- Details
- Written by IVN
Washington, DC - The U.S. Food and Drug Administration today approved Poteligeo injection for intravenous use for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) after at least one prior systemic therapy. This approval provides a new treatment option for patients with MF and is the first FDA approval of a drug specifically for SS.
Page 1171 of 3785